- Companies
- ZAGENO
ZAGENO Funding, Investors & Competitors
ZAGENO has raised $121M across 4 funding rounds, most recently a $33M undisclosed-stage round in May 2023.
Last ZAGENO funding round
$33M
Undisclosed stage · May 2023
Cumulative funding ZAGENO raised
$121M
across 4 funding rounds
Key investors in ZAGENO
Capnamic
Grazia Equity
General Catalyst
HighSage Ventures
FJ Labs
OakRidge Management Group
About ZAGENO
ZAGENO is a procurement marketplace for research labs offering access to over 40 million products from 2,000 suppliers, with automated ordering, real-time inventory, and AI recommendations. The platform consolidates purchases through a metacart system and single creditor model, serving biotech firms, universities, and hospitals. Founded in 2015, ZAGENO operates from Boston, Massachusetts; Berlin, Germany; and Bangalore, India, processing transactions across desktop and mobile interfaces.
Founded
2015
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Commission, Subscription
ZAGENO Funding History
ZAGENO has raised a total of $121M across 4 funding rounds.
ZAGENO's first fundraising round was a $8M Series A in October 2017. The most recent completed round was a $33M undisclosed-stage round in May 2023.
ZAGENO funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| May 2023 | Undisclosed stage | General Catalyst (lead); Grazia Equity (lead); OakRidge Management Group (lead); HighSage Ventures; Capnamic | $33M | ZAGENO is a life sciences eCommerce platform that operates an online marketplace for lab supplies, connecting researchers with over 10,000 suppliers to streamline procurement and deliver cost savings through AI-driven tools and competitive pricing. The company raised $33M in a Series D funding round on May 25, 2023, with participation from General Catalyst, Grazia Equity, OakRidge Management Group, Capnamic, and HighSage Ventures, bringing total funding to approximately $121M across multiple rounds. This investment aims to revolutionize life science research procurement by enhancing efficiency and scalability on their digital platform. ZAGENO has previously completed a Series C in November 2021 and earlier rounds, positioning it as a leader in the biotech and lab supply sector. The platform has been recognized for innovation, including placements in ProcureTech100 and awards from Frost & Sullivan for customer value leadership in lab supply procurement. Post-round developments include continued growth in employee base to around 130-148 and industry accolades. ZAGENO competes in the biotech eCommerce space, focusing on digital transformation for research labs amid challenges in traditional procurement processes. |
| Nov 2021 | Series C | General Catalyst (lead); HighSage Ventures; Capnamic; Grazia Equity | $60M | ZAGENO is a leading enterprise marketplace solution connecting eCommerce to life science research, serving as an online platform for researchers and life science professionals to access laboratory equipment, consumables, chemicals, antibodies, and customized solutions. The company curates research materials and products from premium manufacturing brands, operating offices in San Francisco, Palo Alto, New York City, London, and Boston. In November 2021, ZAGENO announced the completion of a $60 million Series B financing round led by General Catalyst and a large vertically integrated nonprofit healthcare organization. The round also included ongoing investments from Grazia Equity, Capnamic, and HighSage Ventures. The funding was intended to support ZAGENO's goal to champion researchers around the world and advance automation of the supply chain in the life science research industry. The company achieved industry recognition as one of the ProcureTech100's pioneering digital procurement solutions for 2021, and CEO Florian Wegener was recognized by EY as a finalist for Entrepreneur of the Year in both 2020 and 2021. |
| Apr 2019 | Series B | General Catalyst (lead); Capnamic; FJ Labs; Grazia Equity | $20M | ZAGENO is a Cambridge-based e-commerce marketplace for life sciences research products, including chemicals, gene sequencing kits, lab equipment, antibodies, and consumables, enabling scientists to search, compare, and purchase from verified suppliers. Founded in 2015 by Florian Wegener (former cardiologist and biotech executive at QAIGEN/Qiagen) and David Pumberger, the company operates globally with offices in the US, UK, Germany, Belgium, and India, aiming to streamline procurement and accelerate scientific breakthroughs in areas like cancer and tuberculosis. The specified April 2019 funding round, a $20 million Series B led by General Catalyst with participation from Capnamic, Grazia Equity, and FJ Labs (as per query details), brought ZAGENO's total funding at that time toward $88 million cumulatively. General Catalyst continued as a key backer in subsequent rounds, highlighting ZAGENO's role in digital transformation for the life science supply chain. Later rounds included a $60 million financing in November 2021 co-led by General Catalyst and a nonprofit healthcare organization, with ongoing investments from Grazia Equity and Capnamic, used for platform development, engineering expansion, and global hiring. In May 2023, ZAGENO raised $33 million in Series D from General Catalyst, Grazia Equity, OakRidge Management Group, Capnamic, HighSage Ventures, and others, supporting growth in its marketplace serving a $130 billion industry with over 8 million curated products. ZAGENO positions itself as an enabler for researchers by automating supply chains, reducing manual sales processes for suppliers, and offering transparency in pricing and availability, with founders' prior experience at Qiagen driving hundreds of millions in e-commerce revenue there. |
| Oct 2017 | Series A | Capnamic (lead); Grazia Equity | $8M | ZAGENO, an online marketplace connecting scientists, academic research institutes, and biotech manufacturers with life science research products, raised $8 million in a Series A funding round on October 25, 2017. The round was led by Capnamic Ventures, with participation from Grazia Equity, which led the prior seed round. The funding aimed to fuel growth in the USA and Europe by expanding sales, marketing, and technical integration teams. Capnamic Ventures highlighted ZAGENO's exceptional team and its potential to unlock a billion-dollar U.S. market in life science research products. Grazia Equity praised ZAGENO as a game-changer for the life science industry. The company positioned itself at the interface of technology and biotech to meet customer needs on its platform. |
Who has invested in ZAGENO?
6 investors have backed ZAGENO across its funding rounds, including Capnamic, Grazia Equity, General Catalyst, HighSage Ventures, FJ Labs and OakRidge Management Group.
Lead investors include General Catalyst, Grazia Equity, OakRidge Management Group and Capnamic.
ZAGENO Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 4 | Lead | Oct 2017 | ||
| 4 | Lead | Oct 2017 | ||
| 3 | Lead | Apr 2019 | ||
| 2 | Participant | Nov 2021 | ||
This data is available for Pro users. Sign up to see all 6 ZAGENO investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialZAGENO Competitors
ZAGENO competitors include listed companies like Alibaba Group and Manhattan Associates, and private ones like Olist, CADDi, Salla and Meicai.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | - | - | $1.5B | - | ||
| Private | - | - | $1.1B | - | ||
| Publicly listed | $153B | $15B | $266B | 1.6x | ||
| Private | - | - | $1B | - | ||
| Publicly listed | $1.1B | $288M | $12B | 10.6x | ||
| Private | - | - | $7B | - |
ZAGENO Public Comps
ZAGENO is still privately-owned, but its public comps include Alibaba Group, Carvana, Shein, JD Health, Wayfair, Manhattan Associates, Lenskart, Chewy, Descartes Systems Group and Zozo.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $153B | $15B | 1.7x | 1.6x | 17.5x | 13.0x | |||
| $20B | ($110M) | 3.7x | 2.9x | (691.4x) | 27.7x | |||
| $42B | $2.3B | 0.2x | - | 3.5x | - | |||
| $11B | $713M | 0.6x | 0.6x | 9.8x | 8.6x | |||
| $12B | $120M | 1.3x | 1.2x | 136.4x | 19.8x | |||
| $1.1B | $288M | 11.2x | 10.6x | 42.2x | 29.7x | |||
| $916M | $189M | 13.3x | 11.6x | 64.8x | 55.5x | |||
| $13B | $377M | 0.7x | 0.7x | 23.6x | 10.6x | |||
This data is available for Pro users. Sign up to see all ZAGENO competitors and their valuation data. Start Free Trial | ||||||||
Common questions about ZAGENO
| When was ZAGENO founded? | ZAGENO was founded in 2015. |
| Where is ZAGENO headquartered? | ZAGENO is headquartered in United States. |
| Is ZAGENO publicly listed? | No, ZAGENO is a private, VC-backed company. |
| How much funding has ZAGENO raised? | ZAGENO has raised $121M across 4 funding rounds. |
| What was ZAGENO's last funding round? | ZAGENO's last funding round was a $33M undisclosed-stage round in May 2023, led by General Catalyst, Grazia Equity and OakRidge Management Group. |
| Who are ZAGENO's investors? | ZAGENO's investors include Capnamic, Grazia Equity, General Catalyst, HighSage Ventures, FJ Labs and OakRidge Management Group. |
| Which companies are comparable to ZAGENO? | Companies comparable to ZAGENO include Olist, CADDi, Alibaba Group, Salla, Manhattan Associates and Meicai. |
See companies similar to ZAGENO
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




